Cholecalciferol supplementation does not protect against renal allograft structural and functional deterioration: A retrospective study

Transplantation

Volumn 91, Issue 2, 2011, Pages 207-212

  Courbebaisse, Marie ^a   Xu Dubois, Yi Chun ^a   Thervet, Eric ^b   Prié, Dominique ^b   Zuber, Julien ^b   Kreis, Henri ^b   Legendre, Christophe ^b   Rondeau, Eric ^b   Pallet, Nicolas ^a  

^a HÔPITAL TENON   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Cholecalciferol; Chronic allograft nephropathy; Epithelial to mesenchymal transition; Renal transplantation

Indexed keywords

COLECALCIFEROL;

ARTICLE; ATROPHY; CLINICAL ARTICLE; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSING ALVEOLITIS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY DYSFUNCTION; PRIORITY JOURNAL; RENAL PROTECTION; RETROSPECTIVE STUDY; VITAMIN SUPPLEMENTATION;

ADULT; CHOLECALCIFEROL; EPITHELIAL-MESENCHYMAL TRANSITION; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; PEPTIDE FRAGMENTS; PROCOLLAGEN; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 78751644060     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318200ba37     Document Type: Article

References (23)

1. Courbebaisse M, Souberbielle JC, Thervet E. Potential nonclassical effects of vitamin D in transplant recipients. Transplantation 2010; 89: 131.
2. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266.
3. Li M, Batuman V. Vitamin D: A new hope for chronic kidney disease? Kidney Int 2009; 76: 1219.
4. Schwarz U, Amann K, Orth SR, et al. Effect of 1, 25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int 1998; 53: 1696.
5. Tan X, Li Y, Liu Y. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 2006; 17: 3382.
6. Tan X, Wen X, Liu Y. Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling. J Am Soc Nephrol 2008; 19: 1741.
7. Agarwal R, Acharya M, Tian J, et al. Antiproteinuric effect of oral pari-calcitol in chronic kidney disease. Kidney Int 2005; 68: 2823.
8. De Boer IH, Ioannou GN, Kestenbaum B, et al. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2007; 50: 69.
9. Alborzi P, Patel NA, Peterson C, et al. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: A randomized double-blind pilot trial. Hypertension 2008; 52: 249.
10. Akeno N, Matsunuma A, Maeda T, et al. Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney. J Endocrinol 2000; 164: 339.
11. Bhan I, Shah A, Holmes J, et al. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'? Kidney Int 2006; 70: 1486.
12. Pande S, Ritter CS, Rothstein M, et al. FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation. Nephron Physiol 2006; 104: p23.
13. Pascussi JM, Robert A, Nguyen M, et al. Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest 2005; 115: 177.
14. +-dependent phosphate co-transport activity and 1alpha, 25-dihydroxyvitamin D3 production. J Biol Chem 2003; 278: 2206.
15. Halloran PF. Call for revolution: A new approach to describing allograft deterioration. Am J Transplant 2002; 2: 195.
16. Hertig A, Anglicheau D, Verine J, et al. Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol 2008; 19: 1584.
17. Hertig A, Verine J, Mougenot B, et al. Risk factors for early epithelial to mesenchymal transition in renal grafts. Am J Transplant 2006; 6: 2937.
18. Zeisberg M, Strutz F, Muller GA. Renal fibrosis: An update. Curr Opin Nephrol Hypertens 2001; 10:315.
19. Mannon RB. Therapeutic targets in the treatment of allograft fibrosis. Am J Transplant 2006; 6(5 pt 1): 867.
20. Ghoul B, Squalli T, Servais A, et al. Urinary procollagen III aminoter-minal propeptide (PIIINP): A fibrotest for the nephrologist. Clin J Am Soc Nephrol 2010; 5: 205.
21. Teppo A, Tornroth T, Honkanen E, et al. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients. Transplantation 2003; 75: 2113.
22. Courbebaisse M, Thervet E, Souberbielle JC, et al. Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int 2009; 75: 646.
23. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464.